Free Trial

Truist Financial Corp Reduces Stake in Nutex Health Inc. (NASDAQ:NUTX)

Nutex Health logo with Medical background

Truist Financial Corp lessened its position in shares of Nutex Health Inc. (NASDAQ:NUTX - Free Report) by 93.3% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 291,157 shares of the company's stock after selling 4,076,160 shares during the quarter. Truist Financial Corp owned about 5.86% of Nutex Health worth $173,000 at the end of the most recent reporting period.

Nutex Health Trading Up 0.4 %

Shares of NUTX traded up $0.08 during midday trading on Friday, hitting $22.30. 31,821 shares of the stock were exchanged, compared to its average volume of 39,911. Nutex Health Inc. has a 52-week low of $4.16 and a 52-week high of $45.00. The company has a debt-to-equity ratio of 3.04, a quick ratio of 1.55 and a current ratio of 1.59. The stock has a fifty day simple moving average of $20.76 and a 200 day simple moving average of $11.72. The firm has a market cap of $110.88 million, a P/E ratio of -2.11 and a beta of 0.10.

Nutex Health (NASDAQ:NUTX - Get Free Report) last announced its earnings results on Thursday, August 8th. The company reported ($0.07) EPS for the quarter, beating analysts' consensus estimates of ($0.29) by $0.22. The company had revenue of $76.08 million during the quarter. Nutex Health had a negative return on equity of 43.79% and a negative net margin of 13.73%.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on NUTX shares. Maxim Group assumed coverage on shares of Nutex Health in a report on Wednesday, September 18th. They issued a "buy" rating and a $45.00 price objective on the stock. Benchmark boosted their price target on shares of Nutex Health from $30.00 to $45.00 and gave the company a "buy" rating in a research note on Wednesday, August 21st.

Get Our Latest Analysis on Nutex Health

Insider Buying and Selling

In other Nutex Health news, CFO Jon Christian Bates purchased 1,350 shares of the company's stock in a transaction on Thursday, August 22nd. The stock was acquired at an average price of $21.46 per share, for a total transaction of $28,971.00. Following the completion of the purchase, the chief financial officer now directly owns 2,277 shares in the company, valued at approximately $48,864.42. The trade was a 100.00 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 38.52% of the stock is owned by insiders.

Nutex Health Company Profile

(Free Report)

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

Featured Stories

Institutional Ownership by Quarter for Nutex Health (NASDAQ:NUTX)

→ Election rigged? We caught them red-handed… (From Banyan Hill Publishing) (Ad)

Should you invest $1,000 in Nutex Health right now?

Before you consider Nutex Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.

While Nutex Health currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Alphabet Gaining Momentum: Can It Reach $200 by December?

Alphabet Gaining Momentum: Can It Reach $200 by December?

Alphabet (GOOGL) is in the midst of a year-end rally, climbing 10% since September, and some analysts predict it could gain another 30% by Christmas!

Recent Videos

Meta Platforms Tops Most Upgraded Stocks List—Here’s What to Expect
Alphabet Gaining Momentum: Can It Reach $200 by December?
Build-to-Order: The Strategy Fueling Toll Brothers’ Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines